The trajectory of Sildenafil presents a complex case for stakeholders in the medicinal sector. While initially a blockbuster success, generating huge profits, the intellectual property lapse and the subsequent flood of https://escort088691.blogdiloz.com/40312011/the-little-copyright-and-pharma-a-hazardous-investment